Pendulum Therapeutics

Biotechnology, Health Care, Health Diagnostics, Medical, Therapeutics
Founded in 1/1/13
San Francisco, California, United States
http://www.pendulumlife.com
For Profit

About Pendulum Therapeutics

Pendulum Therapeutics believes therapies developed using evidence-based microbiome science and DNA sequencing can help heal the body from within. Armed with 13 patents and 42 pending, the company introduced its flagship product Pendulum Glucose Control, a medical probiotic, in 2020 and demonstrated its efficacy in lowering blood sugar spikes and reducing A1C in a published clinical trial. Founded in 2013 by a diverse team of scientists with deep microbiology, biochemistry, computational, and clinical expertise, Pendulum has raised $111 million to date from Meritech Capital, Sequoia Capital, True Ventures, Khosla Ventures, AME Cloud Ventures and Mayo Clinic among others. Pendulum Therapeutics is headquartered in San Francisco.

Company Metrics

  • Employees: 51-100
  • Monthly Visits: 77069
  • Tech Stack: 22 active products

Financial Information

  • Estimated Revenue: Less than $1M
  • Total Funding: 111200000 USD
  • Last Funding: None (Venture - Series Unknown)
  • Funding Status:

Technology Stack

Pendulum Therapeutics actively uses 22 products in their tech stack.

Market Presence

Industries: Biotechnology, Health Care, Health Diagnostics, Medical, Therapeutics

Headquarters: San Francisco, California, United States

Leadership

Employees